ResearcherKyorin UniversityActive in the last 2 years

Tadakazu Hisamatsu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2271-5141; OpenAlex author ID A5112332619. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-65900-w ↗
Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic cancer. Last author DOI 10.1186/s12876-020-01583-7 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Junji Shibahara · 2 shared papers, 2021–2024 · strength 0.28
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
- Paper Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic canc… DOI 10.1186/s12876-020-01583-7 ↗
Keiichiro Kitahama · 1 shared paper, 2024 · strength 0.17
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
Takahiro Shibayama · 1 shared paper, 2024 · strength 0.17
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
Yoshihiro Sakamoto · 1 shared paper, 2024 · strength 0.17
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
Naohiro Okano · 1 shared paper, 2024 · strength 0.17
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
Akimasa Hayashi · 1 shared paper, 2024 · strength 0.17
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
Christine A. Iacobuzio–Donahue · 1 shared paper, 2024 · strength 0.17
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w ↗
Shunsuke Watanabe · 1 shared paper, 2021 · strength 0.11
- Paper Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic canc… DOI 10.1186/s12876-020-01583-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.